TY - JOUR
T1 - Increased striatal gray matter densities in patients with schizophrenia and substance use disorder
T2 - A voxel-based morphometry study
AU - Potvin, Stéphane
AU - Mancini-Marïe, Adham
AU - Fahim, Chérine
AU - Mensour, Boualem
AU - Lévesque, Johanne
AU - Karama, Sherif
AU - Beauregard, Mario
AU - Rompré, Pierre Paul
AU - Stip, Emmanuel
N1 - Funding Information:
This study was supported by grants from the Fonds de la Recherche en Santé du Québec (FRSQ), AstraZeneca Pharmaceuticals, University of Montreal Eli Lilly Chair of Schizophrenia Fund and the Canadian Institute of Health Research (CIHR). The authors would like to thank Lahcen Aït Bentaleb M.D., Pierre Lalonde M.D., Marcel Wolfe M.D. and Jean M'Pania M.D. for their assistance in patient recruitment.
PY - 2007/4/15
Y1 - 2007/4/15
N2 - We sought to investigate the link between substance abuse and increased striatal gray matter densities (GMD) in schizophrenia, using voxel-based morphometry (VBM). Increased striatal GMD were found in patients with schizophrenia and substance use disorder (n = 12), but not schizophrenia only patients (n = 11), compared to healthy volunteers (n = 15).
AB - We sought to investigate the link between substance abuse and increased striatal gray matter densities (GMD) in schizophrenia, using voxel-based morphometry (VBM). Increased striatal GMD were found in patients with schizophrenia and substance use disorder (n = 12), but not schizophrenia only patients (n = 11), compared to healthy volunteers (n = 15).
KW - Schizophrenia
KW - Substance use disorders
KW - Voxel-based morphometry
UR - http://www.scopus.com/inward/record.url?scp=33947220415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33947220415&partnerID=8YFLogxK
U2 - 10.1016/j.pscychresns.2006.11.009
DO - 10.1016/j.pscychresns.2006.11.009
M3 - Article
C2 - 17341445
AN - SCOPUS:33947220415
SN - 0925-4927
VL - 154
SP - 275
EP - 279
JO - Psychiatry Research - Neuroimaging
JF - Psychiatry Research - Neuroimaging
IS - 3
ER -